Cochlear Ltd Market Cap ($7.19 Billion)

$7.19 Billion USD · AU$10.17 Billion AUD · Rank #2729

Market Cap & Net Worth: Cochlear Ltd (COH)

Cochlear Ltd market cap. Cochlear Ltd (AU:COH) has a market capitalization of $7.19 Billion (AU$10.17 Billion) as of November 7, 2026. Listed on the AU stock exchange, this Australia-based company holds position #2729 globally and #59 in its home market, demonstrating a 9.33% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cochlear Ltd's stock price AU$155.47 by its total outstanding shares 65398462 (65.40 Million). Also see COH operating cash flow for how efficiently the company converts equity into cash flow.

Cochlear Ltd Market Cap History (2015–2026)

Cochlear Ltd market cap history from 2015 to 2026. Data shows growth from $3.87 Billion to $7.19 Billion (6.95% CAGR). Check COH stock price for real-time trading data and today's change.

Index Memberships

Cochlear Ltd is a constituent of 8 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
S&P/ASX 50 AFLI	$1.67 Trillion	0.43%	#40 of 50
Australia All Ordinaries AORD	$2.04 Trillion	0.35%	#51 of 495
S&P/ASX 100 ATOI	$1.91 Trillion	0.38%	#51 of 100
S&P/ASX All Australian 50 AXAF	$1.55 Trillion	0.47%	#39 of 50
S&P/ASX All Australian 200 AXAT	$1.95 Trillion	0.37%	#49 of 200
S&P/ASX 200 AXJO	$1.91 Trillion	0.38%	#50 of 200
S&P/ASX 200 Accumulated AXJOA	$1.91 Trillion	0.38%	#50 of 200
S&P/ASX 300 AXKO	$2.20 Trillion	0.33%	#53 of 300

Weight: Cochlear Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Cochlear Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Cochlear Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Cochlear Ltd annual equity growth to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

5.15x

Cochlear Ltd's market cap is 5.15 times its annual revenue

Industry average: 1.55x Higher than industry average

Latest Price to Earnings (P/E) Ratio

31.01x

Cochlear Ltd's market cap is 31.01 times its annual earnings

Industry average: 18.23x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$5.06 Billion	$1.13 Billion	$188.92 Million	4.48x	26.80x
2017	$7.21 Billion	$1.25 Billion	$223.62 Million	5.75x	32.23x
2018	$7.42 Billion	$1.36 Billion	$245.80 Million	5.44x	30.17x
2019	$9.77 Billion	$1.43 Billion	$276.70 Million	6.85x	35.30x
2020	$8.30 Billion	$1.35 Billion	-$238.30 Million	6.14x	N/A
2021	$9.60 Billion	$1.49 Billion	$326.50 Million	6.43x	29.40x
2022	$9.19 Billion	$1.64 Billion	$289.10 Million	5.60x	31.80x
2023	$13.64 Billion	$1.94 Billion	$300.60 Million	7.04x	45.37x
2024	$13.41 Billion	$2.24 Billion	$356.80 Million	6.00x	37.59x
2025	$12.06 Billion	$2.34 Billion	$388.90 Million	5.15x	31.01x

Competitor Companies of COH by Market Capitalization

Companies near Cochlear Ltd in the global market cap rankings as of November 7, 2026. Also see Cochlear Ltd total assets for a full breakdown of the balance sheet.

Key companies related to Cochlear Ltd by market ranking:

Abbott Laboratories (NYSE:ABT): Ranked #109 globally with a market cap of $191.15 Billion USD.
Stryker Corporation (NYSE:SYK): Ranked #188 globally with a market cap of $124.99 Billion USD.
Medtronic PLC (NYSE:MDT): Ranked #222 globally with a market cap of $109.30 Billion USD.
Medtronic plc (SA:MDTC34): Ranked #233 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#109	Abbott Laboratories	NYSE:ABT	$191.15 Billion	$109.93
#188	Stryker Corporation	NYSE:SYK	$124.99 Billion	$325.87
#222	Medtronic PLC	NYSE:MDT	$109.30 Billion	$101.80
#233	Medtronic plc	SA:MDTC34	$104.84 Billion	R$208.39

Market Capitalization of Cochlear Ltd (2015–2026)

Market capitalization of Cochlear Ltd from 2015 to today. Between 2015 and today, Cochlear Ltd's market cap moved from $3.87 Billion to $ 7.19 Billion, with a yearly change of 6.95%.

Year	Market Cap	Change (%)
2026	AU$7.19 Billion	-40.36%
2025	AU$12.06 Billion	-10.08%
2024	AU$13.41 Billion	-1.64%
2023	AU$13.64 Billion	+48.33%
2022	AU$9.19 Billion	-4.21%
2021	AU$9.60 Billion	+15.66%
2020	AU$8.30 Billion	-15.05%
2019	AU$9.77 Billion	+31.71%
2018	AU$7.42 Billion	+2.91%
2017	AU$7.21 Billion	+42.35%
2016	AU$5.06 Billion	+30.72%
2015	AU$3.87 Billion	--

End of Day Market Cap According to Different Sources

On Nov 7th, 2026 the market cap of Cochlear Ltd was reported to be:

Source	Market Cap
Yahoo Finance	$7.19 Billion USD
MoneyControl	$7.19 Billion USD
MarketWatch	$7.19 Billion USD
marketcap.company	$7.19 Billion USD
Reuters	$7.19 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Cochlear Ltd

AU:COH Australia Medical Devices

Market Cap

$7.19 Billion

AU$10.17 Billion AUD

Market Cap Rank

#2729 Global

#59 in Australia

Share Price

AU$155.47

Change (1 day)

+0.67%

52-Week Range

AU$90.00 - AU$288.39

All Time High

AU$345.53